PMID- 29558533 OWN - NLM STAT- MEDLINE DCOM- 20180921 LR - 20180921 IS - 1552-5783 (Electronic) IS - 0146-0404 (Linking) VI - 59 IP - 4 DP - 2018 Mar 20 TI - Local Progression Kinetics of Geographic Atrophy in Age-Related Macular Degeneration Are Associated With Atrophy Border Morphology. PG - AMD12-AMD18 LID - 10.1167/iovs.17-23203 [doi] AB - PURPOSE: To assess the impact of distinct atrophy border characteristics based on spectral-domain optical coherence tomography (SD-OCT) imaging on local atrophy progression. METHODS: Patients with geographic atrophy (GA) secondary to AMD were recruited in the context of the Longitudinal Fundus Autofluorescence in Age-related Macular Degeneration and Directional Spread in Geographic Atrophy studies (NCT00393692, NCT02051998). Horizontal and vertical SD-OCT scans were acquired at sequential visits using a device allowing for anatomically accurate registration of follow-up to baseline scans. For quantification of local atrophy progression, the lateral spread of GA (LSGA) was measured. Further, border types were independently graded. Comparison of LSGA between the different border types was performed using linear mixed-effects models. RESULTS: Seventy-two eyes of 49 patients (27 female) aged 74.0 years (Inter quartile range [IQR], 68.1-79.0) were included into this analysis. A total of 258 border sections were analyzed longitudinally over a median period of 1.2 years (IQR, 0.9-1.6). At baseline, 17.1% borders were classified as 'regular', 47.7% as 'irregular', and 35.3% as 'splitting'. Sixty-two percent of the eyes exhibited more than one border type. LSGA was slowest in 'regular' borders (62.85 +/- 25.29 mum/y), followed by 'irregular' borders (91.15 +/- 15.05 mum/y) and fastest in 'splitting' borders (183.15 +/- 18.17 mum/y). Differences between the 'splitting' and each other border type were statistically significant (P < 0.001). CONCLUSIONS: The results indicate that SD-OCT-based assessment of local GA border morphology can serve as a predictor for local atrophy progression. These observations help to better understand the natural history and potential pathogenetic factors of GA development and progression. FAU - Lindner, Moritz AU - Lindner M AD - Department of Ophthalmology, University of Bonn, Bonn, Germany. AD - The Nuffield Laboratory of Ophthalmology, Sleep and Circadian Neuroscience Institute, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom. AD - Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom. FAU - Kosanetzky, Sebastian AU - Kosanetzky S AD - Department of Ophthalmology, University of Bonn, Bonn, Germany. FAU - Pfau, Maximilian AU - Pfau M AD - Department of Ophthalmology, University of Bonn, Bonn, Germany. FAU - Nadal, Jennifer AU - Nadal J AD - Institute for Medical Biometry, Informatics and Epidemiology, University Hospital Bonn, Bonn, Germany. FAU - Gordt, Lukas A AU - Gordt LA AD - Department of Ophthalmology, University of Bonn, Bonn, Germany. FAU - Schmitz-Valckenberg, Steffen AU - Schmitz-Valckenberg S AD - Department of Ophthalmology, University of Bonn, Bonn, Germany. FAU - Schmid, Matthias AU - Schmid M AD - Institute for Medical Biometry, Informatics and Epidemiology, University Hospital Bonn, Bonn, Germany. FAU - Holz, Frank G AU - Holz FG AD - Department of Ophthalmology, University of Bonn, Bonn, Germany. FAU - Fleckenstein, Monika AU - Fleckenstein M AD - Department of Ophthalmology, University of Bonn, Bonn, Germany. CN - FAM-Study Group LA - eng SI - ClinicalTrials.gov/NCT00393692 SI - ClinicalTrials.gov/NCT02051998 PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Invest Ophthalmol Vis Sci JT - Investigative ophthalmology & visual science JID - 7703701 SB - IM MH - Aged MH - Aged, 80 and over MH - Atrophy MH - Disease Progression MH - Female MH - Fluorescein Angiography MH - Follow-Up Studies MH - Geographic Atrophy/*diagnosis/etiology MH - Humans MH - Kinetics MH - Macular Degeneration/*complications MH - Male MH - Middle Aged MH - Prospective Studies MH - Retina/diagnostic imaging/*pathology MH - Retinal Pigment Epithelium/diagnostic imaging/*pathology MH - Tomography, Optical Coherence EDAT- 2018/03/21 06:00 MHDA- 2018/09/22 06:00 CRDT- 2018/03/21 06:00 PHST- 2018/03/21 06:00 [entrez] PHST- 2018/03/21 06:00 [pubmed] PHST- 2018/09/22 06:00 [medline] AID - 2675983 [pii] AID - 10.1167/iovs.17-23203 [doi] PST - ppublish SO - Invest Ophthalmol Vis Sci. 2018 Mar 20;59(4):AMD12-AMD18. doi: 10.1167/iovs.17-23203.